Philogen SpA (STU:78Q) Accounts Payable & Accrued Expense : €14.29 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Philogen SpA Accounts Payable & Accrued Expense?

Philogen SpA's quarterly accounts payable & accrued expense increased from Dec. 2023 (€9.76 Mil) to Jun. 2024 (€11.21 Mil) and increased from Jun. 2024 (€11.21 Mil) to Dec. 2024 (€14.29 Mil).

Philogen SpA's annual accounts payable & accrued expense increased from Dec. 2022 (€8.49 Mil) to Dec. 2023 (€9.76 Mil) and increased from Dec. 2023 (€9.76 Mil) to Dec. 2024 (€14.29 Mil).

Philogen SpA Accounts Payable & Accrued Expense Historical Data

The historical data trend for Philogen SpA's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Philogen SpA Accounts Payable & Accrued Expense Chart

Philogen SpA Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

6.84

7.48

8.49

9.76

14.29

Philogen SpA Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial					8.49	10.92	9.76	11.21	14.29

Philogen SpA Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Philogen SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen SpA (STU:78Q) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

PHIL:Italy 78Q:Germany

Address

Piazza La Lizza No. 7, Siena, ITA, 53100

Website

https://www.philogen.com

Philogen SpA is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. The company's focus is predominantly related to oncology drug development, although the company has also brought products for the treatment of chronic inflammatory diseases to the clinic. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, the company operates in the European Union, Switzerland, and the United States of America.

Philogen SpA Headlines

No Headlines